Fingolimod Hydrochloride

brain derived neurotrophic factor ; Mus musculus







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31751571 FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models. 2020 Mar 1
2 32349283 Fingolimod Modulates Dendritic Architecture in a BDNF-Dependent Manner. 2020 Apr 27 6
3 29804232 Early Downregulation of p75NTR by Genetic and Pharmacological Approaches Delays the Onset of Motor Deficits and Striatal Dysfunction in Huntington's Disease Mice. 2019 Feb 1
4 31129200 FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2+/- Mice. 2019 Jul 15 1
5 29530550 Fingolimod inhibits brain atrophy and promotes brain-derived neurotrophic factor in an animal model of multiple sclerosis. 2018 May 15 3
6 30152864 Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor. 2018 Dec 2
7 27439747 Effects of fingolimod administration in a genetic model of cognitive deficits. 2017 May 1
8 27456702 Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis. 2016 Oct 1
9 27528608 FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF. 2016 Sep 23 4
10 26063761 Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation. 2015 Sep 1 2
11 26171219 Antidepressant activity of fingolimod in mice. 2015 Jun 2
12 22891354 Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. 2012 Aug 28 5